Adequan, the “Official Joint Therapy Treatment,” Continues Partnership with USEA
The United States Eventing Association (USEA) is proud to announce that American Regent Animal Health, makers of Adequan i.m.® (polysulfated glycosaminoglycan), will remain a Corporate Sponsor for the 2025 and 2026 seasons.
All Roads Lead to the $60,000 Adequan USEA Advanced Final
The $60,000 Adequan® USEA Advanced Final, which will take place during the 2025 USEA American Eventing Championships presented by Nutrena Feeds on Aug. 26-31, is the highlight of an already jam-packed championship schedule. This year, the championship will be hosted at Galway Downs in Temecula, C...
Gifts Fit for Champions: The USEA Offers Over $100,000 in Prizes at the 2024 AEC
One week from today, nearly 1,000 eager eventing enthusiasts with top qualifications gained at events across the U.S. will converge on Lexington, Kentucky, to fight for champion status at this year’s USEA American Eventing Championship (AEC) presented by Nutrena Feeds!
3 Facts Veterinarians Wish You Knew about DJD
Get a better understanding of degenerative joint disease (DJD) and how you and your veterinarian can work together to help manage the disease in your horse.
Team Approach to Joint Health
From veterinarians to trainers to farriers, everyone in your stable of people helps make the ride more enjoyable—and longer-lasting.
Senior Horse Love—and Health
Proactive wellness care may help horses—and their joints—move comfortably into their golden years, extending their careers and your opportunity for companionship.
Adequan® Continues Partnership with the USEA
The United States Eventing Association, Inc. (USEA) is happy to announce that long-time partner American Regent Animal Health, makers of Adequan® i.m. (polysulfated glycosaminoglycan), will continue their support of the USEA in 2023. Adequan® will return as “The Official Joint Therapy Treatment o...
If You Have a Horse, You Have an Athlete: Tips for Managing Degenerative Joint Disease in Your Equine Athlete
Estimates indicate up to 60 percent of lameness in the horse is related to end-stage degenerative joint disease (DJD), also known as osteoarthritis (OA). DJD can influence performance and significantly impact any horse—from top competitors and weekend warriors to aging seniors.
Four Keys to Limiting Lameness
Mobility matters, so help keep your horse moving with healthy joints and smart healthcare. Lameness. A dreaded word. Uttering it means that your horse may be out of commission. Determining the cause can be challenging, which means treatment—and recovery—can be a long process.
Joint Products 101: Different Types, Different Purposes
From proven arthritis medications to nutritional supplements, understanding the differences among joint product types can make a real difference in your horse’s long-term mobility. Just like horses are similar but different, so are equine joint products. They’re created in different ways, approve...
